drugset
drugset / Trial / NCT04108234

A Study of HR071603(Ketamine Nasal Spray) in Healthy Subjects

NCT04108234 ↗

Phase 1 Completed 50 enrolled Jiangsu HengRui Medicine Co., Ltd.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The study is being conducted to evaluate the safety and pharmacokinetics of HR071603 in healthy subjects.

Timeline

Start
2019-10-24
Primary completion
2021-06-01
Completion
2021-06-01

Drugs

EvaluationDrugModalityDoseRoute
Subject HR071603 Unknown — Intranasal

Indications

depressive disorder